In Vivo Caprine Model for Osteomyelitis and Evaluation of Biofilm-Resistant Intramedullary Nails

Bone infection remains a formidable challenge to the medical field. The goal of the current study is to evaluate antibacterial coatings in vitro and to develop a large animal model to assess coated bone implants. A novel coating consisting of titanium oxide and siloxane polymer doped with silver was created by metal-organic methods. The coating was tested in vitro using rapid screening techniques to determine compositions which inhibited Staphylococcus aureus growth, while not affecting osteoblast viability. The coating was then applied to intramedullary nails and evaluated in vivo in a caprine model. In this pilot study, a fracture was created in the tibia of the goat, and Staphylococcus aureus was inoculated directly into the bone canal. The fractures were fixed by either coated (treated) or non-coated intramedullary nails (control) for 5 weeks. Clinical observations as well as microbiology, mechanical, radiology, and histology testing were used to compare the animals. The treated goat was able to walk using all four limbs after 5 weeks, while the control was unwilling to bear weight on the fixed leg. These results suggest the antimicrobial potential of the hybrid coating and the feasibility of the goat model for antimicrobial coated intramedullary implant evaluation.

[1]  J. Parvizi,et al.  Vancomycin-modified implant surface inhibits biofilm formation and supports bone-healing in an infected osteotomy model in sheep: a proof-of-concept study. , 2012, The Journal of bone and joint surgery. American volume.

[2]  P. Tran,et al.  Nanomaterial-based treatments for medical device-associated infections. , 2012, Chemphyschem : a European journal of chemical physics and physical chemistry.

[3]  A. Klibanov,et al.  Hydrophobic polycationic coatings that inhibit biofilms and support bone healing during infection. , 2012, Biomaterials.

[4]  R. G. Richards,et al.  An in vivo evaluation of surface polishing of TAN intermedullary nails for ease of removal. , 2009, European cells & materials.

[5]  N. Chandrasekaran,et al.  Genotoxicity of silver nanoparticles in Allium cepa. , 2009, The Science of the total environment.

[6]  John D. Jarrell,et al.  Controlled release of vanadium from titanium oxide coatings for improved integration of soft tissue implants. , 2009, Journal of biomedical materials research. Part A.

[7]  John D. Jarrell,et al.  Rapid screening, in vitro study of metal oxide and polymer hybrids as delivery coatings for improved soft-tissue integration of implants. , 2009, Journal of biomedical materials research. Part A.

[8]  E. Wickstrom,et al.  The inhibition of Staphylococcus epidermidis biofilm formation by vancomycin-modified titanium alloy and implications for the treatment of periprosthetic infection. , 2008, Biomaterials.

[9]  David L. Helfet,et al.  Instructional Course Lectures , 2008 .

[10]  George John,et al.  Silver-nanoparticle-embedded antimicrobial paints based on vegetable oil. , 2008, Nature materials.

[11]  J. Calhoun,et al.  Prevention and management of infections associated with combat-related extremity injuries. , 2008, The Journal of trauma.

[12]  Arnab Roy,et al.  Characterization of enhanced antibacterial effects of novel silver nanoparticles , 2007, Nanotechnology.

[13]  Dae Hong Jeong,et al.  Antimicrobial effects of silver nanoparticles. , 2007, Nanomedicine : nanotechnology, biology, and medicine.

[14]  J. Song,et al.  Does the Antibacterial Activity of Silver Nanoparticles Depend on the Shape of the Nanoparticle? A Study of the Gram-Negative Bacterium Escherichia coli , 2007, Applied and Environmental Microbiology.

[15]  S. Rajasekaran,et al.  A score for predicting salvage and outcome in Gustilo type-IIIA and type-IIIB open tibial fractures. , 2006, The Journal of bone and joint surgery. British volume.

[16]  Thomas J Webster,et al.  Increased osteoblast and decreased Staphylococcus epidermidis functions on nanophase ZnO and TiO2. , 2006, Journal of biomedical materials research. Part A.

[17]  C. Şen,et al.  An alternative method for the treatment of nonunion of the tibia with bone loss. , 2006, The Journal of bone and joint surgery. British volume.

[18]  D. Orgill,et al.  Lower Extremity Trauma: Trends in the Management of Soft-Tissue Reconstruction of Open Tibia-Fibula Fractures , 2006, Plastic and reconstructive surgery.

[19]  J. Nanchahal,et al.  Management of severe open tibial fractures: the need for combined orthopaedic and plastic surgical treatment in specialist centres. , 2006, The Journal of bone and joint surgery. British volume.

[20]  P. Giannoudis,et al.  A review of the management of open fractures of the tibia and femur. , 2006, The Journal of bone and joint surgery. British volume.

[21]  J. Schlager,et al.  In vitro cytotoxicity of nanoparticles in mammalian germline stem cells. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.

[22]  M. Yacamán,et al.  The bactericidal effect of silver nanoparticles , 2005, Nanotechnology.

[23]  J. Gearhart,et al.  In vitro toxicity of nanoparticles in BRL 3A rat liver cells. , 2005, Toxicology in vitro : an international journal published in association with BIBRA.

[24]  I. Sondi,et al.  Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria. , 2004, Journal of colloid and interface science.

[25]  R. Gustilo,et al.  OTD classic article review - Gustillo RB, Anderson JT (1976) Prevention of infection in the treatment of one thousand and twenty-five open fractures of long bones: retrospective and prospective analyses , 2002, The Journal of bone and joint surgery. American volume.

[26]  C. Pradier,et al.  Epidemiology of Bacterial Infection During Management of Open Leg Fractures , 1999, European Journal of Clinical Microbiology and Infectious Diseases.

[27]  Jackson Lee,et al.  Efficacy of Cultures in the Management of Open Fractures , 1997, Clinical orthopaedics and related research.

[28]  M. Patzakis,et al.  Factors influencing infection rate in open fracture wounds. , 1989, Clinical orthopaedics and related research.

[29]  R. Gustilo,et al.  Classification of type III (severe) open fractures relative to treatment and results. , 1987, Orthopedics.

[30]  A. Gristina,et al.  Biomaterial-centered infection: microbial adhesion versus tissue integration. , 1987, Science.

[31]  D. N. Williams,et al.  Problems in the management of type III (severe) open fractures: a new classification of type III open fractures. , 1984, The Journal of trauma.

[32]  W. Marsden I and J , 2012 .

[33]  R. Andersen,et al.  From Iraq back to Iraq: modern combat orthopaedic care. , 2008, Instructional course lectures.